174 related articles for article (PubMed ID: 30945048)
1. Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study.
Bruce DG; Davis TME; Davis WA
Acta Diabetol; 2019 Jul; 56(7):767-776. PubMed ID: 30945048
[TBL] [Abstract][Full Text] [Related]
2. Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I.
Davis WA; Zilkens RR; Starkstein SE; Davis TM; Bruce DG
Diabetologia; 2017 Jan; 60(1):89-97. PubMed ID: 27717960
[TBL] [Abstract][Full Text] [Related]
3. Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study.
Paul Chubb SA; Davis WA; Peters KE; Davis TM
Cardiovasc Diabetol; 2016 Oct; 15(1):143. PubMed ID: 27716263
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study.
Schimke K; Chubb SA; Davis WA; Davis TM
Atherosclerosis; 2010 Sep; 212(1):321-6. PubMed ID: 20839379
[TBL] [Abstract][Full Text] [Related]
5. Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study.
Hamilton E; Davis WA; Bruce DG; Davis TM
J Clin Endocrinol Metab; 2017 Feb; 102(2):551-559. PubMed ID: 27880070
[TBL] [Abstract][Full Text] [Related]
6. The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes Study.
Davis WA; Starkstein SE; Bruce DG; Davis TM
J Diabetes Complications; 2015; 29(8):1320-2. PubMed ID: 26387807
[TBL] [Abstract][Full Text] [Related]
7. Earlier age of dementia onset and shorter survival times in dementia patients with diabetes.
Zilkens RR; Davis WA; Spilsbury K; Semmens JB; Bruce DG
Am J Epidemiol; 2013 Jun; 177(11):1246-54. PubMed ID: 23543134
[TBL] [Abstract][Full Text] [Related]
8. Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study.
Davis TM; Drinkwater J; Davis WA
Diabet Med; 2014 Aug; 31(8):913-9. PubMed ID: 24661305
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.
Bruce DG; Davis WA; Starkstein SE; Davis TM
Diabetologia; 2005 Dec; 48(12):2532-9. PubMed ID: 16292463
[TBL] [Abstract][Full Text] [Related]
10. Association of moderate and vigorous physical activity with incidence of type 2 diabetes and subsequent mortality: 27 year follow-up of the Whitehall II study.
Yerramalla MS; Fayosse A; Dugravot A; Tabak AG; Kivimäki M; Singh-Manoux A; Sabia S
Diabetologia; 2020 Mar; 63(3):537-548. PubMed ID: 31792574
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Drinkwater JJ; Davis TME; Turner AW; Bruce DG; Davis WA
Diabetes Care; 2019 Feb; 42(2):288-296. PubMed ID: 30523034
[TBL] [Abstract][Full Text] [Related]
12. Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis.
Gauci R; Hunter M; Bruce DG; Davis WA; Davis TME
J Diabetes Complications; 2017 Jul; 31(7):1169-1174. PubMed ID: 28433448
[TBL] [Abstract][Full Text] [Related]
13. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Yeap BB; Davis WA; Bruce DG
Diabetologia; 2008 Apr; 51(4):562-6. PubMed ID: 18193189
[TBL] [Abstract][Full Text] [Related]
14. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study.
Zhu L; Fratiglioni L; Guo Z; Basun H; Corder EH; Winblad B; Viitanen M
Stroke; 2000 Jan; 31(1):53-60. PubMed ID: 10625715
[TBL] [Abstract][Full Text] [Related]
15. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.
Bo S; Gentile L; Castiglione A; Prandi V; Canil S; Ghigo E; Ciccone G
Eur J Endocrinol; 2012 Aug; 167(2):173-80. PubMed ID: 22577110
[TBL] [Abstract][Full Text] [Related]
16. Self-awareness of foot health status in patients with Type 2 diabetes: the Fremantle Diabetes Study Phase II.
Baba M; Foley L; Davis WA; Davis TM
Diabet Med; 2014 Nov; 31(11):1439-45. PubMed ID: 24925259
[TBL] [Abstract][Full Text] [Related]
17. The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Chubb SA; Davis WA
Eur J Endocrinol; 2016 Oct; 175(4):273-85. PubMed ID: 27418062
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men.
Yeap BB; McCaul KA; Flicker L; Hankey GJ; Almeida OP; Golledge J; Norman PE
J Clin Endocrinol Metab; 2015 Mar; 100(3):1038-47. PubMed ID: 25548977
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.
Magliano DJ; Davis WA; Shaw JE; Bruce DG; Davis TM
Eur J Endocrinol; 2012 Oct; 167(4):589-99. PubMed ID: 22893694
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study.
Zakaria MH; Davis WA; Davis TM
Diabet Med; 2014 Apr; 31(4):425-30. PubMed ID: 24151882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
